NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.

Jean Bourhis, Anne Auperin, Christian Borel, Gautier Lefebvre, Severine Racadot, Lionnel Geoffrois, Xu Shan Sun, Esma Saada, Beatriz Cirauqui, Tomasz Rutkowski, Stephanie Henry, Anouchka Modesto, Alison Johnson, Benoit Calderon, Yoann Pointreau, Elisabeth Perez Ruiz, Joanna Kazmierska, Amanda Psyrri, Ricard Mesia, Yungan Tao

J Clin Oncol 43, 2025 (suppl 17; abstr LBA2)